Santen Pharmaceutical (OTCMKTS:SNPHY) Shares Gap Up – Here’s Why

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $11.23, but opened at $12.0850. Santen Pharmaceutical shares last traded at $12.04, with a volume of 492 shares trading hands.

Santen Pharmaceutical Stock Performance

The firm has a 50 day simple moving average of $12.48 and a two-hundred day simple moving average of $11.69.

About Santen Pharmaceutical

(Get Free Report)

Santen Pharmaceutical Co, Ltd. is a Japan‐based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over‐the‐counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post‐operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.

With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.

See Also

• Five stocks we like better than Santen Pharmaceutical
• NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
• Dropping the Dough: Yum! Brands Strategically Trims the Fat
• These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
• One of Trump’s Favorite Stocks Just Reported Blowout Earnings

Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.